Evelo Biosciences’ $25.5 Million Private Placement

Pietro Martinoia
Tagged:

Goodwin advised Flagship Pioneering on the investment.Evelo Biosciences, Inc. (Nasdaq:EVLO) announced a securities purchase agreement with investors in a private placement to sell 11,025,334 shares of its…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

…

This content is for Standard 1 Year members only.
Login Join Now